|Bid||26.12 x 1000|
|Ask||26.20 x 800|
|Day's Range||25.43 - 26.36|
|52 Week Range||14.93 - 32.12|
|Beta (5Y Monthly)||2.01|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 11, 2021 - May 17, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||39.63|
NGM Biopharmaceuticals (NGM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
There's no doubt that money can be made by owning shares of unprofitable businesses. By way of example, NGM...
NGM Biopharmaceuticals (NGM) delivered earnings and revenue surprises of 14.89% and -14.45%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?